Skip to main content
Intensive Care Medicine Experimental

Table 2 Clinical endpoints in patients with or without viral reactivation

From: Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19

 

No reactivation N = 45

Viral reactivation N = 75

P value

In-hospital death

22 (49%)

52 (69%)

0.026

ICU–BSI

19 (42%)

45 (60%)

0.059

VAP

17 (38%)

46 (61%)

0.012

LOS, days

12 [6–19]

27 [13–42]

0.001

  1. ICU–BSI (Intensive Care Unit Bloodstream Infections), VAP (Ventilator-Associated Pneumonia), LOS (Length of Stay)
Back to article page